According to the latest status from June 2024, JCR Pharmaceuticals Co paid a total of 20 JPY per share in dividends within the last 12 months. With the current JCR Pharmaceuticals Co price of 577 JPY, this corresponds to a dividend yield of 3.47 %. A dividend is paid times per year.
| 3.47 % Dividend Yield | = |
|
A dividend is paid times per year. Last year, the payout months were April and October.
| Paydate | Dividend |
|---|---|
| 4/28/2024 | 10 |
| 10/28/2023 | 10 |
| 4/30/2023 | 10 |
| 10/29/2022 | 10 |
| 4/30/2022 | 10 |
| 10/29/2021 | 10 |
| 4/30/2021 | 7 |
| 10/29/2020 | 4.5 |
| 4/30/2020 | 17 |
| 10/27/2019 | 15 |
| 4/27/2019 | 17 |
| 10/26/2018 | 13 |
| 4/28/2018 | 14 |
| 10/27/2017 | 12 |
| 4/29/2017 | 12 |
| 10/28/2016 | 10 |
| 4/29/2016 | 10 |
| 10/28/2015 | 10 |
| 4/27/2015 | 10 |
| 10/26/2014 | 8.5 |
The dividend per year chart for JCR Pharmaceuticals Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.
A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify JCR Pharmaceuticals Co’s potential for long-term investment and income generation through dividends.
Incorporate the dividend data in evaluating JCR Pharmaceuticals Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.
| Date | JCR Pharmaceuticals Co Dividend |
|---|---|
| 2027e | 24.25 undefined |
| 2026e | 24.2 undefined |
| 2025e | 24.33 undefined |
| 2024e | 24.24 undefined |
| 2023 | 20 undefined |
| 2022 | 20 undefined |
| 2021 | 17 undefined |
| 2020 | 8.75 undefined |
| 2019 | 8 undefined |
| 2018 | 6.75 undefined |
| 2017 | 6 undefined |
| 2016 | 5 undefined |
| 2015 | 5 undefined |
| 2014 | 2.88 undefined |
| 2013 | 3.25 undefined |
| 2012 | 3 undefined |
| 2011 | 3 undefined |
| 2010 | 2.75 undefined |
| 2009 | 2.5 undefined |
| 2008 | 2.5 undefined |
| 2007 | 2.5 undefined |
| 2006 | 2.75 undefined |
| 2005 | 3 undefined |
| 2004 | 3 undefined |
| Dividend | Dividend (Estimate) | |
|---|---|---|
| 2004 | 3 JPY | 0 JPY |
| 2005 | 3 JPY | 0 JPY |
| 2006 | 2.75 JPY | 0 JPY |
| 2007 | 2.5 JPY | 0 JPY |
| 2008 | 2.5 JPY | 0 JPY |
| 2009 | 2.5 JPY | 0 JPY |
| 2010 | 2.75 JPY | 0 JPY |
| 2011 | 3 JPY | 0 JPY |
| 2012 | 3 JPY | 0 JPY |
| 2013 | 3.25 JPY | 0 JPY |
| 2014 | 2.88 JPY | 0 JPY |
| 2015 | 5 JPY | 0 JPY |
| 2016 | 5 JPY | 0 JPY |
| 2017 | 6 JPY | 0 JPY |
| 2018 | 6.75 JPY | 0 JPY |
| 2019 | 8 JPY | 0 JPY |
| 2020 | 8.75 JPY | 0 JPY |
| 2021 | 17 JPY | 0 JPY |
| 2022 | 20 JPY | 0 JPY |
| 2023 | 20 JPY | 0 JPY |
| 2024e | 0 JPY | 24.24 JPY |
| 2025e | 0 JPY | 24.33 JPY |
| 2026e | 0 JPY | 24.2 JPY |
| 2027e | 0 JPY | 24.25 JPY |
JCR Pharmaceuticals Co has been increasing the dividend for 7 years.
Over the past 10 years, JCR Pharmaceuticals Co has increased it by an annual 19.926 %.
Over a five-year period, the distribution increased by 24.264%.
Analysts expect a Dividend Increase of 10.08% for the current fiscal year.
JCR Pharmaceuticals Co’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Examining JCR Pharmaceuticals Co's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
JCR Pharmaceuticals Co's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Changes in JCR Pharmaceuticals Co’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Over the past 12 months, JCR Pharmaceuticals Co paid a dividend of 20 JPY . This corresponds to a dividend yield of about 3.47 %. For the coming 12 months, JCR Pharmaceuticals Co is expected to pay a dividend of 24.33 JPY.
The current dividend yield of JCR Pharmaceuticals Co is 3.47 %.
JCR Pharmaceuticals Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.
JCR Pharmaceuticals Co paid dividends every year for the past 24 years.
For the upcoming 12 months, dividends amounting to 24.33 JPY are expected. This corresponds to a dividend yield of 4.22 %.
JCR Pharmaceuticals Co is assigned to the 'Health' sector.
To receive the latest dividend of JCR Pharmaceuticals Co from 6/1/2024 amounting to 10 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.
The last dividend was paid out on 6/1/2024.
In the year 2023, JCR Pharmaceuticals Co distributed 20 JPY as dividends.
The dividends of JCR Pharmaceuticals Co are distributed in JPY.
Our stock analysis for JCR Pharmaceuticals Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of JCR Pharmaceuticals Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
